The modified 5-item frailty index predicts long-term mortality after breast cancer surgery in elderly women: A five-year follow-up study
Resumen: Purpose: Frailty is a major determinant of outcomes in older adults with cancer, and its identification in surgical oncology patients provides an opportunity to enhance perioperative care. However, the association of frailty with long-term outcomes remains poorly characterized. This study evaluated the prognostic value of the modified 5-item frailty index (mFI-5) in predicting long-term survival among elderly women undergoing breast cancer surgery. Methods: A retrospective observational study was conducted including 290 women aged ≥70 years who underwent breast cancer surgery between 2016 and 2021. Frailty was assessed using the mFI-5 and categorized as fit (score = 0), pre-frail (score = 1), and frail (score ≥2). Long-term survival rates were analyzed across age groups, tumor subtypes, and TNM stages, stratified by mFI-5 category. Results: Frailty was identified in 37.2% of patients and was strongly associated with reduced long-term overall survival (52.6% in frail vs. 88.4% in fit patients at 5 years). Multivariable Cox regression confirmed frailty as an independent predictor of mortality (HR 3.14, p = 0.003), primarily driven by non-cancer related deaths. The prognostic performance of the mFI-5 was consistent across all subgroups analyzed. Conclusion: The mFI-5 is a simple and practical tool that identifies elderly women with breast cancer at increased risk of long-term mortality following surgery. Incorporating the mFI-5 into routine preoperative evaluation may facilitate improved treatment planning and outcomes.
Idioma: Inglés
DOI: 10.1016/j.suronc.2026.102369
Año: 2026
Publicado en: SURGICAL ONCOLOGY-OXFORD 65 (2026), 102369 [6 pp.]
ISSN: 0960-7404

Tipo y forma: Article (PostPrint)
Área (Departamento): Área Cirugía (Dpto. Cirugía)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you may not distribute the modified material.


Fecha de embargo : 2027-02-12
Exportado de SIDERAL (2026-02-24-14:47:47)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Cirugía



 Record created 2026-02-24, last modified 2026-02-25


Postprint:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)